Synthesis of Some Novel D-Dihomo-aza- and D-Dihomo-oxa-steroid Derivatives in the Estrone Series

Abstract

New heteroestrone derivatives with a seven-membered ring D were efficiently synthesized from unsaturated carboxylic ­estrone-secoaldehyde 1 via multistep reactions.

Michael addition - condensation - cyclization - lactams - D-dihomoestrone derivatives

References

1 Camoutsis C. Trafalis DTP. Invest. New Drugs  2003,  21:  47 

2 Papageorgiu A. Nikolaropoulos SS. Arsenou ES. Karaberis E. Mourelatos D. Kotsis A. Chryssogelou E. Chemotherapy  1999,  45:  61 

3 Catsoulacos P. Boutis L. Cancer Chem. Rep.  1973,  57:  365 

4a Thompson IM. Klein EA. Lippman SM. Coltman CA. Djavan B. Eur. Urol.  2003,  44:  650 

4b McConnell JD. Roehrborn CG. Bautista OM. Andriole GL. Dixon CM. Kusek JW. Lepor H. McVary KT. Nyberg LM. Clarke HS. Crawford ED. Diokno A. Foley JP. Foster HE. Jacobs SC. Kaplan SA. Kreder KJ. Lieber MM. Lucia MS. Miller GJ. Menon M. Milam DF. Ramsdell JW. Schenkman NS. Slawin KM. Smith JA. N. Engl. J. Med.  2003,  349:  2387 

4c Roehrborn C. Boyle P. Nickel J. Hoefner K. Andriole G. Urology  2002,  60:  434 

4d Dull P. Reagan RW. Bahnson RR. Am. Fam. Physician  2002,  66:  77 

5a Gordee R. Butler T. J. Antibiot.  1975,  28:  112 

5b Burbiel J. Bracher F. Steroids  2003,  68:  587 

6a Xie WG. Peng HR. Zalkow LH. Li YH. Zhu C. Powis G. Kunkel M. Bioorg. Med. Chem.  2000,  8:  699 

6b Kasal A. Matyá L. Budìínsk M. Tetrahedron  2005,  61:  2269 

7 Lázár L. Kivelä H. Pihlaja K. Fülöp F. Tetrahedron Lett.  2004,  45:  6199 

8a Koutsourea AI. Arsenou ES. Fousteris MA. Nikolaropoulos SS. Steroids  2003,  68:  659 

8b Athanasiou C. Catsoulacos P. Papageorgiou A. Athanasiou K. Cancer Invest.  1987,  5:  301 

9 Catsoulacos P. Pairas G. Papageorgiou A. J. Heterocycl. Chem.  1995,  32:  1063 

10a Eadon G. Popov S. Djerassi C. J. Am. Chem. Soc.  1972,  94:  1282 

10b Djerassi C. Popov S. Eadon G. J. Org. Chem.  1972,  37:  155 

10c Eadon G. Djerassi C.
J. Med. Chem.  1972,  15:  89 

11 Tietze LF. Sommer KM. Schneider G. Tapolcsányi P. Wölfling J. Müller P. Noltemeyer M. Terlau H. Synlett  2003,  1494 

12a Guzzi U. Marnini G. Gazz. Chim. Ital.  1977,  107:  75 

12b Schneider G. Vincze I. Hackler L. Dombi G. Synthesis  1983,  665 

13

Compound 19 (C₂₇H₄₄N₂O₃): colorless oil; R _f = 0.26 (MeOH). ¹H NMR (500 MHz, MeOD): δ = 0.96 (t, 3 H, J = 7.4 Hz) and 1.00 [t, 3 H, J = 7.4 Hz, 2 × propyl-CH₃], 1.07 (s, 3 H, 18-H₃), 2.80 (m, 2 H, 6-H₂), 3.72 (s, 3 H, 3-OMe), 6.57 (d, 1 H, J = 2.5 Hz, 4-H), 6.66 (dd, 1 H, J = 8.6 Hz, J = 2.5 Hz, 2-H), 7.15 (d, 1 H, J = 8.6 Hz, 1-H). ¹³C NMR (125 MHz, MeOD): δ = 11.7 and 12.1 (2 × propyl-CH₃), 16.9 (C-18), 21.2, 23.6, 28.3, 28.7, 31.3, 34.0, 36.6 (C-16), 39.0, 44.1, 44.9, 46.3, 48.9 (C-13), 50.6 (N-CH₂), 51.9 (N-CH₂), 54.0 (N-CH₂), 55.7 (3-OMe), 55.8 (N-CH₂), 112.9 (C-2), 114.4 (C-4), 127.8 (C-1), 133.6 (C-10), 138.7 (C-5), 159.0 (C-3), 187.4 (C-17).

14

Compound 24 (C₂₄H₃₃NO₂): colorless crystals, mp 178-180 °C. R _f = 0.57 (MeOH). ¹H NMR (500 MHz, DMSO-d ₆): δ = 0.91 (t, 3 H, J = 7.4 Hz, propyl-CH₃), 1.07 (s, 3 H, 18-H₃), 2.71 (m, 2 H, 6-H₂), 3.50 (m, 2 H, 16a′-H₂), 3.68 (s, 3 H, 3-OMe), 5.24 (s, 1 H) and 5.26 (s, 1 H): 16a-H₂, 6.58 (d, 1 H, J = 2.5 Hz, 4-H), 6.66 (dd, 1 H, J = 7.6 Hz, J = 2.5 Hz, 4-H), 7.15 (d, 1 H, J = 7.6 Hz, 1-H). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 11.0 (propyl-CH₃), 15.0 (C-18), 18.6, 25.6, 27.0, 29.8, 35.9, 36.3, 41.4, 42.4, 42.5, 46.5 (C-13), 48.0 and 50.8 (propyl N-CH₂ and C-16a′), 54.8 (3-OMe), 111.6 (C-2), 113.0 (C-4), 115.8 (C-16a), 126.3 (C-1), 131.7 (C-10), 137.3 (C-5), 140.4 (C-16), 157.0 (C-3), 179.4 (C-17).

15

Compound 28 (C₂₇H₄₂N₂O₂): colorless oil; R _f = 0.24 (MeOH-CH₂Cl₂ = 5:95). ¹H NMR (500 MHz, DMSO-d ₆): δ = 0.81 (t, 3 H, J = 7.4 Hz) and 0.87 (t, 3 H, J = 7.4 Hz, 2 × propyl-CH₃), 1.13 (s, 3 H, 18-H₃), 2.74 (m, 2 H, 6-H₂), 3.67 (s, 3 H, 3-OMe), 6.60 (d, 1 H, J = 2.5 Hz, 4-H), 6.67 (dd, 1 H, J = 8.6 Hz, J = 2.5 Hz, 2-H), 7.16 (d, 1 H, J = 8.6 Hz, 1-H). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 11.2 and 11.5 (2 × propyl-CH₃), 15.8 (C-18), 20.4, 21.6, 25.4, 27.2, 29.6, 33.5, 37.5, 39.8, 41.2, 42.1, 43.7, 45.1 (C-13), 50.7, 50.9, 52.3 and 52.9 (2 × propyl N-CH₂, C-16a and C-16a′), 54.8 (3-OMe), 111.4 (C-2), 112.7 (C-4), 125.8 (C-1), 132.6 (C-10), 137.4 (C-5), 157.1 (C-3), 177.2 (C-17).

16a Peach JM. Pratt AJ. Snaith JS. Tetrahedron  1995,  51:  10013 

16b Nakajima K. Erne D. Bean JW. Sargent DF. Schwyzer R. Paterson SJ. Kosterlitz HW. Tetrahedron  1988,  44:  721 

17 Xu G. Liu Y. Sayre LM. J. Org. Chem.  1999,  64:  5732 

18

Compound 37 (C₂₁H₂₆O₃): colorless crystals, mp 135-137 °C. R _f = 0.39 (CH₂Cl₂). ¹H NMR (500 MHz, CDCl₃): δ = 1.20 (s, 3 H, 18-H₃), 2.86 (m, 2 H, 6-H₂), 3.77 (s, 3 H, 3-OMe), 4.56 (d, 1 H, J = 10.9 Hz) and 4.69 (d, 1 H, J = 10.9 Hz): 16a′-H₂, 5.20 (s, 1 H) and 5.25 (s, 1 H): 16a-H₂, 6.63 (d, 1 H, J = 2.3 Hz, 4-H), 6.72 (dd, 1 H, J = 8.6 Hz, J = 2.3 Hz, 2-H), 7.19 (d, 1 H, J = 8.6 Hz, 1-H). ¹³C NMR (125 MHz, CDCl₃): δ = 15.6 (C-18), 26.1, 26.5, 29.9, 37.0, 38.8, 40.2, 42.3, 43.3, 47.8 (C-13), 55.1 (3-OMe), 72.2 (C-16a′), 111.6 (C-2), 113.3 (C-4), 120.2 (C-16a), 126.2 (C-1), 131.9 (C-10), 137.4 (C-5), 141.8 (C-16), 157.6 (C-3), 181.2 (C-17).

19

Compound 38 (C₂₁H₂₆O₃): colorless crystals, mp 190-192 °C. R _f = 0.45 (CH₂Cl₂). ¹H NMR (500 MHz, CDCl₃): δ = 1.22 (s, 3 H, 18-H₃), 1.82 (s, 3 H, 16a-H₃), 2.83 (m, 2 H, 6-H₂), 3.78 (s, 3 H, 3-OMe), 4.80 (d, 1 H, J = 10.8 Hz, 15-H), 5.16 (s, 1 H) and 5.26 (s, 1 H): 16a′-H₂, 6.61 (d, 1 H, J = 2.5 Hz, 4-H), 6.72 (dd, 1 H, J = 8.7 Hz, J = 2.5 Hz, 4-H), 7.18 (d, 1 H, J = 8.7 Hz, 1-H). ¹³C NMR (125 MHz, CDCl₃): δ = 15.2 (C-18), 16.5 (C-16a), 25.5, 26.0, 29.3, 31.9, 36.5, 43.0 (C-13), 43.7, 51.4, 55.2 (3-OMe), 85.5 (C-15), 111.7 (C-2), 113.8 (C-4), 118.7 (C-16a′), 126.3 (C-1), 131.0 (C-10), 137.2 (C-5), 141.7 (C-16), 157.7 (C-3), 180.1 (C-17). The compounds give correct elemental analyses.